79 results
Page 2 of 4
8-K
EX-99.1
mqnw9us9dyaxi4n
14 Sep 22
POINT Biopharma Prices Public Offering of Common Stock
4:14pm
8-K
EX-99.1
1g47okmy2awxaoi75
13 Sep 22
POINT Biopharma Announces Proposed Public Offering of Common Stock
4:12pm
8-K
EX-99.1
8ceg3q5h
12 Sep 22
POINT Biopharma Provides Updated Efficacy and Safety Data from the Lead-In Cohort of the Phase 3 SPLASH Trial in mCRPC at ESMO Congress 2022
7:54am
8-K
EX-99.1
61q5je3q453n5fd a3
6 Sep 22
POINT Biopharma Announces Poster Presentation at ESMO Congress 2022 Containing Efficacy & Safety Data from Lead-In Cohort of Phase 3 SPLASH Trial
8:11am
S-3
EX-1.2
0dppaae
1 Jul 22
Shelf registration
4:13pm
424B3
EX-99.1
4qhzk3d45w3ouqd qm
16 May 22
Prospectus supplement
8:27am
8-K
EX-99.1
1irmv
16 May 22
Other Events
8:20am
424B3
ktxy0c6
31 Mar 22
Prospectus supplement
11:42am
POS AM
u43om3wr9 qr31g
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
8-K
EX-99.1
eas8z2
25 Mar 22
POINT Biopharma Reports Fiscal 2021 Financial Results and Provides Business Update
8:22am
424B3
EX-99.2
0hrr0m4bw5uw4jxc
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.2
68z2hugol0xktmdlwrpz
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
EX-99.1
5jwms 7irpyt7w9eg0nr
1 Dec 21
Prospectus supplement
8:25am
8-K
EX-99.1
wu6ixt9hzlkgo7q
1 Dec 21
Departure of Directors or Certain Officers
8:14am
424B3
EX-10.1
t699o4o
12 Nov 21
Prospectus supplement
8:41am
424B3
h18p11hu z8
28 Sep 21
Prospectus supplement
9:07am
8-K
EX-99.1
nqrz3maaltx
28 Sep 21
Entry into a Material Definitive Agreement
8:53am